In this interview Matt Crawford speaks with author Jim Geraghty about his book, Inside the Orphan Drug Revolution. Advances in medicine have made treatments for severe illnesses more common place but what about those thousands of classified "rare" diseases that still affect hundreds of thousands? The drug that treat these can be prohibitive to produce and can become Orphan drugs, that manufacturers are unwilling to produce. Where does that leave those individuals who suffer from them and their families? Geraghty brings his many years of experience to bear and introduces us to some of those families who have suffered this very scenario.